LCZ696 Therapy Reduces Ventricular Tachyarrhythmia Inducibility in a Myocardial Infarction-Induced Heart Failure Rat Model
Open Access
- 1 July 2019
- journal article
- research article
- Published by Wiley in Cardiovascular Therapeutics
- Vol. 2019, 1-9
Abstract
Background. LCZ696 (valsartan/sacubitril) therapy significantly reduced mortality in patients with heart failure (HF). Although a clinical trial (PARADISE-MI Trial) has been ongoing to examine the effects of LCZ696 in myocardial infarction (MI) patients, the effects of LCZ696 on remodeling of cardiac electrophysiology in animal models remain largely unclear. Methods. We performed coronary artery ligation to create MI in Sprague-Dawley rats. Echocardiography was performed one week after MI to confirm the development of HF with left ventricular ejection fraction ≤ 40%. MI rats were randomly assigned to receive medical therapy for 4 weeks: LCZ696, enalapril, or vehicle. The sham-operation rats received sham operation without MI creation. In vivo electrophysiological exams were performed under general anesthesia. Western blot analyses were conducted to quantify ion channel proteins. Results. The HF-vehicle group did not show significant changes in LVEF. Both enalapril and LCZ696 therapy significantly improved LVEF. The HF-vehicle group had higher ventricular arrhythmia (VA) inducibility than the sham group. As compared with the HF-vehicle group, LCZ696 therapy significantly reduced VA inducibility, but enalapril therapy did not. Western blot analyses showed significant downregulation of 1.5, ERG, KCNE1, and KCNE2 channel proteins in the HF vehicle group compared with the sham group. LCZ696 therapy upregulated protein expression of ERG, KCNE1, and KCNE2. Conclusion. As compared with enalapril therapy, LCZ696 therapy led to improvement of LVEF, reduced VA inducibility, and upregulated expression of K+ channel proteins.
Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (105-2314-B-182A-099, 104)
- Taiwan Society of Cardiology (105-2314-B-182A-099, 104)
This publication has 27 references indexed in Scilit:
- Remote Past Left Ventricular Function before Chronic Right Ventricular Pacing Predicts Responses to Cardiac Resynchronization Therapy UpgradePacing and Clinical Electrophysiology, 2013
- Cardiac ventricular repolarization reserve: a principle for understanding drug-related proarrhythmic riskBritish Journal of Pharmacology, 2011
- Acute Myocardial Infarction in RatsJournal of Visualized Experiments, 2011
- Epidemiology and risk profile of heart failureNature Reviews Cardiology, 2010
- Survival and Cardiac Remodeling Benefits in Patients Undergoing Late Percutaneous Coronary Intervention of the Infarct-Related ArteryJACC, 2008
- Arrhythmogenic Ion-Channel Remodeling in the Heart: Heart Failure, Myocardial Infarction, and Atrial FibrillationPhysiological Reviews, 2007
- Antiarrhythmic effect of carvedilol after acute myocardial infarctionJACC, 2005
- Regulation of Gene Expression by Cyclic GMPCirculation Research, 2003
- Losartan and Its Metabolite E3174 Modify Cardiac Delayed Rectifier K+CurrentsCirculation, 2000
- Indications for ACE Inhibitors in the Early Treatment of Acute Myocardial InfarctionCirculation, 1998